Schizophrenia Clinical Trial
Official title:
Personal Identity, Cognitive Factors and Psychotic Symptoms in Schizophrenia and Related Disorders: A Cross-sectional Study With the Repertory Grid Technique
NCT number | NCT03820362 |
Other study ID # | FPU15/01721 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 2016 |
Est. completion date | November 2018 |
Verified date | January 2019 |
Source | University of Barcelona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Personal identity is being recently recognized as a core element for mental health disorders, with relevant clinical implications. However, scarcity of data exists on its role in schizophrenia and related disorders. The repertory grid (RGT), a technique derived from personal construct theory, has been used in different clinical and non-clinical contexts for the study of the construction perception of self and others, to appreciate aspects of interpersonal construing such as polarization and differentiation (unidimensional thinking) or self-construction.and Our study aims to explore the potential influence of the structure of personal identity and of other relevant cognitive factors (social cognition, metacognition, neurocognition) in positive and negative symptoms in people suffering schizophrenia and related disorders.
Status | Completed |
Enrollment | 85 |
Est. completion date | November 2018 |
Est. primary completion date | November 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - diagnosis of schizophrenia, psychotic disorder not otherwise specified, delusional disorder, schizoaffective disorder, brief psychotic disorder, or schizophreniform disorder - age between 18 and 60 years. - patients from outpatient mental health units Exclusion Criteria: - traumatic brain injury, dementia, or intellectual disability (pre-morbid IQ <70) - current substance dependence |
Country | Name | City | State |
---|---|---|---|
Spain | Parc Sanitary Sant Joan de Déu | Sant Boi De Llobregat | Barcelona |
Lead Sponsor | Collaborator |
---|---|
University of Barcelona | Agència de Gestió d'Ajuts Universitaris i de Recerca, Catalunya, Spain, Ministerio de Educación y Formación Profesional, Spain, Parc Sanitari Sant Joan de Déu |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-ideal discrepancy, RGT | Self-esteem. Possible range: 0-0,60. Higher values represent a worse outcome | 2 hours | |
Primary | Self-others discrepancy, RGT | Perceived social isolation. Possible range: 0-0,60. Higher values represent a worse outcome | 2 hours | |
Primary | Interpersonal construct differentiation, RGT | Percentage of Variance Accounted for the First Factor. Possible range: 0-100. Higher values represent a worse outcome | 2 hours | |
Primary | Polarization, RGT | Dichotomous thinking style in the interpersonal context. Possible range: 0-100. Higher values represent a worse outcome | 2 hours | |
Primary | Number of elicited constructs, RGT | Quantity of constructs that the person is able to express to describe self and others. Possible range: 10-50. Higher values represent a better outcome | 2 hours | |
Primary | Psychotic symptoms (PANSS, Kay et al. 1987; Peralta & Cuesta, 1994). | Positive and negative symptoms of psychosis. Range: 7-112. Higher values represent a worse outcome. | 40 minutes | |
Primary | Metacognition: BCIS (Beck et al. 2004; Gutiérrez-Zotes et al. 2012); Garety et al, 1991; Dudley et al, 1997) | Cognitive insight. Range: 0-45. Higher values represent a better outcome | 15 minutes | |
Primary | Theory of mind: the Hinting Task (Corcoran et al., 1995; Gil-Sanz et al., 2012) | Possible range: 0-12. Higher values represent a better outcome | 5 minutes | |
Primary | General intellectual functioning (WAIS) | vocabulary subscale. Range: 70-140. Higher values represent a better outcome | 20 minutes | |
Primary | Executive functioning: WSCT (Bergs et al., 1948) | Wisconsin Card Sorting Test. Categories completed and perseverative errors. Higher values represent a better outcome | 15 minutes | |
Secondary | Sociodemographical data | Gender, chronicity, antipsychotic dosage, diagnosis, age, marital status, education level, employment situation | 10 minutes | |
Secondary | Depressive symptoms | Beck Depression Inventory (Beck et al. 1996; Sanz, Perdigón & Vázquez, 2003). Range_ 0-63. High values represent a worse outcome. | 10 minutes | |
Secondary | General functioning | Global Assessment of Functioning (Endicot et al., 1976). Range: 0-100. Higher values represent a better outcome. | 5 minutes | |
Secondary | Self-esteem | Rosenberg self-esteem scale (Martín Albó et al., 2007). Range: 0-40. Higher values represent a better outcome | 5 minutes | |
Secondary | Social functioning | Social Functioning Scale (Birchwood et al., 1990; Torres & Olivares, 2000). Range: Range: 45-195 | 20 minutes | |
Secondary | Psychological distress | CORE-OM (Evans et al., 2002; Trujillo et al., 2016). Range: 0-4. Higher values represent a worse outcome | 10 minutes | |
Secondary | Jumping to Conclusions | The beads task (Garety et al., 1991; Dudley et al, 1997). Dichotomous: yes/no. A "yes" represents a worse outcome | 15 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |